Picoplatin

N/A

Report date: 2022/11/25 16:34:12
NME

Base Information

Drug NamePicoplatin
Drug Alias Name吡铂picoplatinepicoplatinopicoplatinumPicoplatin +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsSolid tumoursUrinary Bladder Neoplasms +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaBulgariaCanada +[18] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesAnormedPoniard Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaxter Oncology GmbhAstrazeneca PlcNational Cancer Institute +[4] 
Active IndicationsN/A
Inactive IndicationsHormone-Resistant Prostate NeoplasmsSolid tumoursUrinary Bladder Neoplasms +[14] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG